Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418077 · ClinicalTrials.gov registry record · NA
Post-Exercise Cardiovascular Responses Following Energy Drink Consumption
A NA study, sponsored by David Grant U.S. Air Force Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03418077: Completed NA study, sponsored by David Grant U.S. Air Force Medical Center.
NCT03418077 is a NA study that has completed, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03418077, a NA study, has completed, sponsored by David Grant U.S. Air Force Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of consuming an original flavor energy drink on electrocardiographic (ECG) and hemodynamic responses during and after exercise in healthy subjects. The effect of drinking an energy drink on exercise performance will also be evaluated.
Primary Outcome
QTc interval will be obtained by 12-lead ECG at baseline (prior to consumption of study drink), after consuming the drink and immediately following exercise and at 1, 4, 7 and 10 min following exercise while standing, and again at 30-minute intervals for a total of 2 hours (after being seated for 5 minutes prior) after exercise. Measures will be obtained at two visits (i.e., one visit for the placebo drink and one visit for the energy drink), separated by 4 - 14 days. The values for each partici
Interventions
- DIETARY_SUPPLEMENT Energy Drink
- DIETARY_SUPPLEMENT Placebo-control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03418077 record still lists
NCT03418077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Energy Drink is the first listed.
NCT03418077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03418077 about?
NCT03418077 is a clinical study titled "Post-Exercise Cardiovascular Responses Following Energy Drink Consumption". The purpose of this study is to determine the effects of consuming an original flavor energy drink on electrocardiographic (ECG) and hemodynamic responses during and after exercise in healthy subjects. The effect of drinking an energy drink on exercise performance will also be evaluated.
What is the current status of trial NCT03418077?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-05-07. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03418077?
The interventions under investigation include: Energy Drink (DIETARY_SUPPLEMENT), Placebo-control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03418077?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03418077's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI